Bloomberg/Bloomberg via Getty Images Modern (NASDAQ:mRNA) is scheduled to release its fourth-quarter 2023 results before the opening bell on Thursday, ...
AAPS;The current controversy over alleged DNA contamination of COVID-19 vaccines involves complex issues and also shows the difficulties of getting ...